PCRX · Pacira BioSciences, Inc. · Documents
$36.38
-0.02 (-0.05%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$1.45B
Shares
39.86M
Volume · Oct 28
429.94K
Avg daily vol (3M)
1.24M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2020-10-30 | 2020-09-30 | |
| 8-K | — | 2020-10-29 | — | |
| 8-K | — | 2020-10-07 | — | |
| 8-K | — | 2020-09-09 | — | |
| 10-Q | — | 2020-08-06 | 2020-06-30 | |
| 8-K | — | 2020-08-06 | — | |
| 8-K/A | — | 2020-08-06 | — | |
| 8-K | — | 2020-07-10 | — | |
| 8-K | — | 2020-07-06 | — | |
| 8-K | — | 2020-07-02 | — | |
| 8-K | — | 2020-06-11 | 2020-06-05 | |
| 10-Q | — | 2020-05-07 | 2020-03-31 | |
| 8-K | — | 2020-05-07 | — | |
| DEFA14A | — | 2020-04-24 | — | |
| DEF 14A | — | 2020-04-24 | 2020-06-08 | |
| 10-K | — | 2020-02-21 | 2019-12-31 | |
| 8-K | — | 2020-02-20 | — | |
| 8-K | — | 2020-01-10 | — | |
| 8-K | — | 2020-01-09 | — |
Showing 151–169 of 169 filings
Key facts
CIK
1396814
CUSIP
695127100
13F (30d)
51 filings
50 filers
Visit website
Investor relations